Infection with the virus that causes COVID-19 can trigger an immune response that lasts well beyond the initial infection and recovery – even among people who had mild symptoms or no symptoms at all, according to Cedars-Sinai investigators. The findings are published in the Journal of Translational Medicine.
COVID-19 can trigger self-attacking antibodies
January 3, 2022